Submitted by srtariqu on Sun, 01/31/2016 - 2:04pm
New study by Charbonneau member Dr. Aaron Goodarzi finds one in eight southern Alberta homes exceeds Health Canada's acceptable radon level.
Dr. Marco Gallo, Member of the Charbonneau Cancer Institute and the Alberta Children's Hospital Research Institute was one of two recipients of the ACGT Young Investigator Grant for his research into the cellular anomalies in glioblastoma brain cancer.
Alex's Lemonade Stand Foundation (ALSF) awarded Psychosocial grants to four researchers across North America. Charbonneau member Dr. Fiona Schulte receives the Psychosocial Launch Grant for her study on factors that may be contributing to social adjustment difficulties in pediatric brain tumor survivors.
Charbonneau member Dr. Hans Vogel, Professor in the Department of Biochemistry at the University of Calgary and his team of researchers identified a molecular switch in L-plastin, a calcium binding protein known to play a significant role in the metastasis, or spread, of cancer cells.
Dr. Oliver Bathe, Charbonneau member and University of Calgary Cumming School of Medicine researcher, describes a new blood test that might replace current screening methods for colorectal cancer.
University of Calgary's 2016 iGEM team in collaboration with Charbonneau members just returned from presenting their work at the International Genetically Engineered Machine (iGEM) competition in Boston. The group of 15 students, supervised by Dr. Mayi Arcellana-Panlilio received a gold medal.
Dr. Friedenreich recognized for her contributions to the health sciences
Charbonneau graduate student Dan Berger, Supervised by Dr. Jennifer Chan and Dr. Aaron Goodarzi awarded the Killam doctoral scholarship.
Charbonneau member and researcher Dr. David Schriemer has been investigating the enzymes of a species of tropical pitcher plant which show promise in assisting the human digestion of gluten linked to celiac disease.
The work of Dr. Arjumand Wani, Postdoctoral Fellow working in the laboratory of Dr. Susan Lees-Miller has revealed the potential of targeting the hyperactive PI3K pathway that deregulates cell growth, to overcome the chemo-resistance displayed by cervical cancer patients.
With patient input, Charbonneau member, Shane Sinclair develops a tool to benchmark delivery of compassionate care
The University of Calgary’s 2016 iGEM team (in collaboration with members of the Arnie Charbonneau Cancer Institute) has chosen to tackle to problem of DNA damage.
Dr. Donna Senger awarded a Canadian Cancer Society (CSC) Innovation Grant on her work “Targeting neutrophil recruitment in cancer metastasis”.
Charbonneau member Dr. Barry Bultz Director, Department of Psychosocial and Rehabilitation Oncology is one of the recipients of the Alberta Order of Excellence. The order is the province’s highest honour a citizen can receive and is an official part of the Canadian Honours System.
Congratulations to Charbonneau researchers Dr. Savraj Grewal and Dr. Ebba Kurz who both have been awarded funding from the Natural Sciences and Engineering Research Council of Canada (NSERC).
Data from a study co-authored by Charbonneau member Dr. Nizar Bahlis was approved by FDA for the use of ixazomib in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma. This study has been published in the New England Journal of Medicine April 28, 2016.
The vast majority of Canadians who pass away from cancer do not die from their primary cancer; they die after the disease metastasizes to another organ – such as the liver, lungs or brain. Charbonneau members Dr. Robbins and Dr. Senger's research could have a major impact on cancer survival rates
For more than 20 years, Dr. Aru Narendran has been on the quest to help find new and better cures for kids with cancer.
The Arnie Charbonneau Cancer Institute is pleased to offer a limited number Alex R. Cummings Trainee* Travel Awards valued at maximum $750.00 each towards conference registration.
Congratulations to Charbonneau researchers, Dr. Jennifer Cobb and Dr. Tara Beattie who qualified to run in the 2016 Boston Marathon.
A new study from Dr. Daniel Heng, clinical associate at the Arnie Charbonneau Cancer Institute and Department of Oncology has shown that men with metastatic testicular cancer who are disease-free two years after dignosis and treatment have a cure rate of 98 percent. For this work Dr. Danny Heng has been awarded the prestigious Cumming School of Medicine’s Research (Clinical)Award for clinical, adjunct, and research faculty.
Dr. Robbie Loewith, former PhD student at the Faculty of Medicine (now the Cumming School) from 1994 to 2000, Loewith says the University of Calgary is “where I learned how to become a real scientist and what research is all about.” He is currently a full professor in the department of Molecular Biology at the University of Geneva.
Dr. Gareth Williams, Dr. Marco Gallo and Dr. Anne Vaahtokari join the Charbonneau team.
Dr. Steve Robbins and Dr. Donna Senger awarded a Canadian Cancer Society Impact Grant for their work on “A novel approach to targeting organ-selective metastasis”
The 2nd Annual Cancer Research Symposium of the Charbonneau Cancer Institute was held on Friday, February 5th.
Scientist Carrie Shemanko’s latest study helps to advance understanding of the complex biology of cancer
Pilot study helps develop new province-wide screening criteria for earlier detection
Congratulations to Dr. Aaron Goodarzi who was named one of Avenue Magazine's top 40 Calgarian's under 40!
Dr. Jennifer Chan was introduced as the new holder of the Kids Cancer Care Chair in Pediatric Oncology.